Choi, Dong-Ju
Inserm · University of Mannheim · National and Kapodistrian University of Athens · Heidelberg University · University of Mississippi Medical Center · Universitätsklinikum des Saarlandes · German Centre for Cardiovascular Research · Défaillance Cardiovasculaire Aiguë et Chronique · Charité – Universitätsmedizin Berlin · RWTH Aachen University · Université de Lorraine
3 papers on CoChatORCID 0000-0003-0146-2189
Most cited papers
- Verified
Cardiovascular and renal outcomes with empagliflozin in heart failure
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine
Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 5,206
- Verified
Empagliflozin in heart failure with a preserved ejection fraction
Anker, S. D., Butler, J., Filippatos, G., Ferreira, J. P., Bocchi, E., Böhm, M., Brunner–La Rocca, H.-P., Choi, D.-J., Chopra, V., Chuquiure-Valenzuela, E., et al. (2021) · New England Journal of Medicine
Heart Failure Treatment and ManagementDiabetes Treatment and Management
Cited by 4,874
- Verified
Artificial Intelligence for the Diagnosis of Heart Failure
Choi, D.-J., Park, J. J., Ali, T., & Lee, S. (2020) · npj Digital Medicine
Artificial Intelligence in HealthcareArtificial Intelligence in Healthcare and Education
Cited by 163
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free